In large animal models of hypoxic pulmonary hypertension (PHTN) that closely parallel human disease, the earliest pulmonary artery (PA) smooth muscle cell (SMC) proliferative changes occur at the medial/adventitial border. Migration of SMC and/or myofibroblasts to more distal vessels is also a prominent feature. A murine model that adequately mimics these hypoxia-induced changes has not been described. Neutral endopeptidase (NEP; or neprilysin) is an important cell surface peptidase that degrades vasoactive neuropeptides (like the bombesin-like peptides [BLPs]), that may promote vascular remodeling. NEP has also been shown to directly engage in intracellular signaling by novel peptidase independent mechanisms. Finally, NEP has recently been associated with decreased inflammation, carcinogenesis and growth. These observations support the possibility that in the lung (in contrast to the heart and systemic vasculature) NEP could exert a protective effect on susceptibility to hypoxic PHTN. We now have strong preliminary evidence to support this concept. We have found that targeted deletion of NEP in mice predisposes to exaggerated hypoxic PHTN. The resulting structural changes are more substantial than in previously described mouse models and for the first time demonstrate proximal changes at the medial/adventitial border. Recruitment of dedifferentiated SMC or myofibroblasts into the distal circulation is also a major feature. This unique pattern of vascular remodeling, together with intriguing observations in the literature, suggest key roles for BLPs, BLP receptors, selected isozymes of protein kinase C (PKC alpha, delta, and epsilon), Rho, and focal adhesion kinase (FAK). The following hypotheses will be tested: #1) NEP protects the lung vasculature from the development of hypoxic PHTN and limits vascular remodeling by suppressing the proliferation, migration, and contraction of PA SMC. #2) Selected neuropeptides (initial focus: BLPs) are largely responsible for the exaggerated pulmonary vascular remodeling observed in the chronically hypoxic NEP knockout (KO) mouse. Hypoxia- induced upregulation of BLPs and BLP receptors contributes to the increased medial/adventitial changes. #3) Upregulation of BLP post-receptor signaling intermediates (PKC a, delta , and epsilon, Rho, and FAK) contributes to the exaggerated remodeling. NEP inhibits these signaling intermediates as well as proliferation and migratory responses of PA SMC by peptidase dependent and independent mechanisms. Integrated experiments will be performed in single and double KO mice, perfused lungs, isolated pulmonary arteries and PA SMC. These studies will draw on a unique mouse model of hypoxia-induced pulmonary vascular remodeling to increase our understanding of the mechanisms that control susceptibility to hypoxic-PHTN and could identify new therapeutic targets to limit or reverse this important clinical problem.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL014985-31
Application #
6728398
Study Section
Project Start
2003-04-01
Project End
2008-03-31
Budget Start
2003-04-01
Budget End
2008-03-31
Support Year
31
Fiscal Year
2003
Total Cost
$224,186
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Jiang, Xinguo; Nicolls, Mark R; Tian, Wen et al. (2018) Lymphatic Dysfunction, Leukotrienes, and Lymphedema. Annu Rev Physiol 80:49-70
Schäfer, Michal; Humphries, Stephen; Stenmark, Kurt R et al. (2018) 4D-flow cardiac magnetic resonance-derived vorticity is sensitive marker of left ventricular diastolic dysfunction in patients with mild-to-moderate chronic obstructive pulmonary disease. Eur Heart J Cardiovasc Imaging 19:415-424
D'Alessandro, Angelo; El Kasmi, Karim C; Plecitá-Hlavatá, Lydie et al. (2018) Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming. Antioxid Redox Signal 28:230-250
Karoor, Vijaya; Fini, Mehdi A; Loomis, Zoe et al. (2018) Sustained Activation of Rho GTPases Promotes a Synthetic Pulmonary Artery Smooth Muscle Cell Phenotype in Neprilysin Null Mice. Arterioscler Thromb Vasc Biol 38:154-163
Stenmark, Kurt R; Graham, Brian B (2018) Urocortin 2: will a drug targeting both the vasculature and the right ventricle be the future of pulmonary hypertension therapy? Cardiovasc Res 114:1057-1059
Madhavan, Krishna; Frid, Maria G; Hunter, Kendall et al. (2018) Development of an electrospun biomimetic polyurea scaffold suitable for vascular grafting. J Biomed Mater Res B Appl Biomater 106:278-290
Stenmark, Kurt R; Frid, Maria G; Graham, Brian B et al. (2018) Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension. Cardiovasc Res 114:551-564
Schäfer, Michal; Kheyfets, Vitaly O; Barker, Alex J et al. (2018) Reduced shear stress and associated aortic deformation in the thoracic aorta of patients with chronic obstructive pulmonary disease. J Vasc Surg 68:246-253
Graham, Brian B; Kumar, Rahul; Mickael, Claudia et al. (2018) Vascular Adaptation of the Right Ventricle in Experimental Pulmonary Hypertension. Am J Respir Cell Mol Biol 59:479-489
Wick, Marilee J; Harral, Julie W; Loomis, Zoe L et al. (2018) An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse. J Vis Exp :

Showing the most recent 10 out of 148 publications